Vaxart, Inc.
VXRT
$0.3181
-$0.0258-7.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 28.70M | 16.76M | 13.93M | 8.89M | 7.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.70M | 16.76M | 13.93M | 8.89M | 7.38M |
| Cost of Revenue | 74.21M | 66.26M | 66.20M | 67.53M | 68.14M |
| Gross Profit | -45.51M | -49.50M | -52.27M | -58.65M | -60.76M |
| SG&A Expenses | 20.78M | 22.20M | 22.78M | 23.20M | 22.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 94.99M | 88.46M | 88.98M | 90.73M | 90.73M |
| Operating Income | -66.29M | -71.70M | -75.05M | -81.85M | -83.35M |
| Income Before Tax | -66.69M | -72.08M | -75.38M | -81.47M | -82.20M |
| Income Tax Expenses | 260.00K | 258.00K | 279.00K | 277.00K | 261.00K |
| Earnings from Continuing Operations | -66.95 | -72.34 | -75.66 | -81.74 | -82.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -66.95M | -72.34M | -75.66M | -81.74M | -82.47M |
| EBIT | -66.29M | -71.70M | -75.05M | -81.85M | -83.35M |
| EBITDA | -57.44M | -62.76M | -66.26M | -73.11M | -74.72M |
| EPS Basic | -0.35 | -0.42 | -0.47 | -0.54 | -0.58 |
| Normalized Basic EPS | -0.22 | -0.26 | -0.29 | -0.34 | -0.36 |
| EPS Diluted | -0.35 | -0.42 | -0.47 | -0.54 | -0.58 |
| Normalized Diluted EPS | -0.22 | -0.26 | -0.29 | -0.34 | -0.36 |
| Average Basic Shares Outstanding | 808.55M | 722.82M | 647.39M | 602.28M | 568.68M |
| Average Diluted Shares Outstanding | 808.55M | 722.82M | 647.39M | 602.28M | 568.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |